Skip Navigation
Skip to contents

Allergy Asthma Respir Dis.  2015 Mar;3(2):155-158. 10.4168/aard.2015.3.2.155.

Successful rapid desensitization to trimethoprim-sulfamethoxazole-induced delayed hypersensitivity

Affiliations
  • 1Department of Internal Medicine, Seoul National University Medical Research Center, Seoul National University College of Medicine, Seoul, Korea. helenmed@snu.ac.kr
  • 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul National University College of Medicine, Seoul, Korea.
  • 3Regional Pharmacovigilance Center, Seoul National University Hospital, Seoul, Korea.

Abstract

Trimethoprim-sulfamethoxazole (TMP-SMX) is an antibiotic used for the treatment or prophylaxis of Pneumocystis pneumonia and other infectious conditions. Sulfonamide derivatives have been reported to cause delayed hypersensitivity reactions, resulting in switch to less effective second-line antibiotics. Although desensitization is traditionally known to be effective in patients with immediate hypersensitivity, it is also applied to the treatment of delayed hypersensitivity in recent years. A 66-year-old female who had a history of repeated TMP-SMX-induced delayed hypersensitivity presenting as whole body rashes needed to take prophylactic dose of TMP-SMX (80/400 mg daily) before initiation of chemotherapy for multiple myeloma. Intravenous rapid desensitization was performed by using a 11-step, 4-bottle protocol from 1:1,000 to 1:1 solution for 3 hours to reach the target dose for prophylaxis. After successful rapid desensitization of TMP-SMX, 1-month prophylaxis was completed without any complications until the patient recovered normal immunity. We herein reported a case of delayed hypersensitivity reaction to TMP-SMX in an about-to-be immunocompromised host with planned chemotherapy who successfully completed 1-month prophylaxis with the drug without any complications through rapid desensitization.

Keyword

Sulfamethoxazole; Trimethoprim; Delayed hypersensitivity; Immunologic desensitization

MeSH Terms

Aged
Anti-Bacterial Agents
Desensitization, Immunologic
Drug Therapy
Exanthema
Female
Humans
Hypersensitivity, Delayed*
Hypersensitivity, Immediate
Immunocompromised Host
Multiple Myeloma
Pneumonia, Pneumocystis
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination
Anti-Bacterial Agents
Sulfamethoxazole
Trimethoprim
Full Text Links
  • AARD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr